Evaluating risks and benefits in coronary revascularisation-a very imperfect art?

Heart

Volumn 95, Issue 1, 2009, Pages 6-8

  De Belder, Mark A ^a   Hamilton, Leslie ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

ANGIOCARDIOGRAPHY; CLINICAL DECISION MAKING; CLINICAL EVALUATION; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE CLASSIFICATION; EDITORIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; INFORMED CONSENT; LONG TERM CARE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK BENEFIT ANALYSIS; SCORING SYSTEM; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING; VALIDATION STUDY;

ACUTE CORONARY SYNDROME; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; HUMANS; INFORMED CONSENT; MYOCARDIAL REVASCULARIZATION; PATIENT CARE TEAM; RISK ASSESSMENT;

EID: 58349096257     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2007.141440     Document Type: Editorial

References (21)

1. Myers WO, Blackstone EH, Davis K, et al. CASS registry long term surgical survival. Coronary Artery Surgical Study. J Am Coll Cardiol 1999; 33:488-98.
2. Detre KM, Takaro T, Hultgren H, et al. Long-term mortality and morbidity results of the Veterans Administration randomized trial of coronary artery bypass surgery. Circulation 1985. 72:V84-9.
3. Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery. Survival of patients with a low ejection fraction. N Engl J Med 1985; 312:1665-71.
4. European Coronary Surgery Study Group. Longterm results of prospective andomised study of coronary bypass surgery in stable angina pectoris. Lancet 1982; 2:1173-80.
5. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356:1503-16.
6. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117:1283-91.
7. Ong AT, Serruys PW, Mohr FW, et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase. Am Heart J 2006; 151:1194-204.
8. Nashef SAM, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardio-thorac Surg 1999; 16:9-13.
9. Michel P, Roques F, Nashef SA, et al. Logistic or additive Euroscore for high risk groups? Eur J Cardiothorac Surg 2003; 23:684-7.
10. Anderson RP. First publications from the Society of Thoracic Surgeons' national database. Ann Thorac Surg 1994; 57:6-7.
11. Bhatti F, Grayson AD, Grotte G, et al. The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk? Heart 2006; 92:1817-20.
12. Singh M, Lennon RJ, Holmes DR Jr, et al. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002; 40:387-93.
13. Grayson AD, Moore RK, Jackson M, et al. Multivariate prediction of major adverse cardiac events after 9914 percutaneous coronary interventions in the north west of England Heart 2006; 92:658-63.
14. Singh M, Gersh BJ, Li S, et al. Mayo Clinic risk score for percutaneous coronary intervention predicts hospital mortality in patients undergoing coronary artery bypass graft surgery Circulation 2008; 117:333-5.
15. Romagnoli E, Burzotta F, Trani C, et al. Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention Heart 2009; 95:43-8
16. Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction a convenient, bedside, clinical score for risk assessment at presentation An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy. Circulation 2000; 102: 2031-7.
17. Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI Risk Score) Am J Cardiol 2004; 93:629-32.
18. Sianos G, Morel M-A, Kappetein A-P. et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. Eurolnterv 2005; 1:219-27.
19. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation Ml: a methof for prognostication and therapeutic decision making. JAMA 2000; 284:835-42.
20. Eagle KA, Lim MJ, Dabbous OH, et al. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry JAMA 2004; 291:2727-33.
21. National Confidential Enquiry into Patient Outcome and Death. Death following a first time. isolated coronary artery bypass graft. The heart of the matter. A report of the National Confidential Enquiry into Patient Outcome and Death, 2008. http://www ncepod.org.uk/2008cabg.htm